Twenty-Eight Cases of Extraocular Sebaceous Carcinoma: A Correlative Clinicopathological and Immunohistochemical Analysis of Extraocular Sebaceous Carcinomas and Benign Sebaceous Gland Tumors.

Extraocular sebaceous carcinoma (ESC) is a rare appendiceal skin tumor. In contrast to ocular sebaceous carcinoma, information about the exact cellular architecture of these lesions is scarce and the histogenesis of ESC is unknown. Here, we extend our previous study and investigate 28 extraocular carcinomas in comparison to 54 benign sebaceous tumors and 8 cases of normal sebaceous glands using a broad spectrum of antibodies against p63, several keratins, adipophilin, EMA, Ki67, androgen receptor, and mismatch repair proteins. This observational study demonstrates that p63- and K5/14-positive basaloid cells are key cells in normal sebaceous gland and in all sebaceous tumors and that these basaloid cells give rise to EMA+, adipophilin+ sebocytes, and K5/14+, K7±, K10± ductal structures. Finally, about half of ESC is associated with superficial in situ neoplasia, which provides evidence that at least part of these carcinomas arises from flat superficial in situ carcinoma. In contrast to the normal sebaceous gland, about half of all sebaceous tumors lack keratin K7. MMR protein IHC-profiles role will be discussed.

[1]  M. Tiemann,et al.  Spatial analysis of p63, K5 and K7 defines two groups of progenitor cells that differentially contribute to the maintenance of normal sebaceous glands, extraocular sebaceous carcinoma and benign sebaceous tumors , 2019, The Journal of dermatology.

[2]  Y. Okazaki,et al.  Prevalence and molecular characteristics of DNA mismatch repair protein-deficient sebaceous neoplasms and keratoacanthomas in a Japanese hospital-based population , 2018, Japanese journal of clinical oncology.

[3]  Charles J. Vaske,et al.  Cell of origin and mutation pattern define three clinically distinct classes of sebaceous carcinoma , 2018, Nature Communications.

[4]  M. Tiemann,et al.  Multiple immunolabeling with antibodies from the same host species in combination with tyramide signal amplification. , 2018, Acta histochemica.

[5]  M. Asgari,et al.  Sebaceous carcinoma in situ as a concept and diagnostic entity , 2017, Dermatology practical & conceptual.

[6]  Su Kyung Park,et al.  Sebaceous Carcinoma: Clinicopathologic Analysis of 29 Cases in a Tertiary Hospital in Korea , 2017, Journal of Korean medical science.

[7]  E. Guenova,et al.  Infundibulocystic Structures and Prominent Squamous Metaplasia in Sebaceoma—A Rare Feature. A Clinicopathologic Study of 10 Cases , 2016, The American Journal of dermatopathology.

[8]  M. Michal,et al.  Aggressive Extraocular Sebaceous Carcinoma of the Scalp Involving the Brain in a Patient With Muir–Torre Syndrome , 2016, The American Journal of dermatopathology.

[9]  M. Redston,et al.  Importance of universal mismatch repair protein immunohistochemistry in patients with sebaceous neoplasia as an initial screening tool for Muir-Torre syndrome. , 2016, Human pathology.

[10]  Christopher J. Miller,et al.  Management Considerations in Extraocular Sebaceous Carcinoma , 2016, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[11]  S. Suster,et al.  Role of Immunohistochemistry in the Diagnosis of Sebaceous Carcinoma: A Clinicopathologic and Immunohistochemical Study , 2015, The American Journal of dermatopathology.

[12]  Y. Xu,et al.  Unusual presentation of metastatic sebaceous carcinoma and its response to chemotherapy: is genotyping a right answer for guiding chemotherapy in rare tumours? , 2015, Current oncology.

[13]  Y. Narisawa,et al.  Sebaceous carcinoma in association with actinic keratosis: A report of two cases with an immunohistochemical study , 2015, The Journal of dermatology.

[14]  B. Al-Nawas,et al.  Multifocal Metastasizing Extra-Ocular Facial Sebaceous Carcinoma as Diagnostic Challenge: Case Report and Systematic Review , 2015, Journal of Maxillofacial and Oral Surgery.

[15]  A. Moore,et al.  Defective DNA mismatch repair activity is common in sebaceous neoplasms, and may be an ineffective approach to screen for Lynch syndrome , 2015, Familial Cancer.

[16]  E. Hurst,et al.  Sebaceous Carcinoma: Review of the Literature , 2015, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[17]  Marc D. Brown Commentary on Sebaceous Carcinoma , 2015, Dermatologic Surgery.

[18]  V. White,et al.  Periocular sebaceous gland carcinoma: do androgen receptor (NR3C4) and nuclear survivin (BIRC5) have a prognostic significance? , 2014, Acta ophthalmologica.

[19]  H. Nakagawa,et al.  Bowen's carcinoma of the penis with sebaceous differentiation associated with human papillomavirus type 16 , 2014, International journal of dermatology.

[20]  J. Plaza,et al.  Intraepithelial sebaceous carcinoma: a case report of an unusual occurrence. , 2014, The American Journal of dermatopathology.

[21]  V. White,et al.  Sebaceous carcinoma: clinicopathologic features and diagnostic role of immunohistochemistry (including androgen receptor). , 2014, Canadian journal of ophthalmology. Journal canadien d'ophtalmologie.

[22]  E. Fuchs,et al.  Plasticity of epithelial stem cells in tissue regeneration , 2014, Science.

[23]  H. Choung,et al.  Prognostic value of clinical and pathologic T stages defined by the American Joint Committee on Cancer for eyelid sebaceous carcinoma in Korea , 2014, Japanese Journal of Ophthalmology.

[24]  S. Leyvraz,et al.  Long-Term Remission of an Aggressive Sebaceous Carcinoma following Chemotherapy , 2014, Case Reports in Dermatology.

[25]  F. Jakobiec,et al.  Androgen receptor identification in the diagnosis of eyelid sebaceous carcinomas. , 2014, American journal of ophthalmology.

[26]  J. Eshleman,et al.  DNA mismatch repair defects and microsatellite instability status in periocular sebaceous carcinoma. , 2014, American journal of ophthalmology.

[27]  H. Okabe,et al.  Sebaceous carcinoma associated with Bowen's disease: a case report with emphasis on the pathogenesis of sebaceous carcinoma. , 2013, International journal of clinical and experimental pathology.

[28]  M. Hoang,et al.  Perilipin and adipophilin expression in sebaceous carcinoma and mimics. , 2013, Human pathology.

[29]  L. Pincus,et al.  Cutaneous Adnexal Tumors , 2012 .

[30]  M. Tiemann,et al.  Signal amplification in immunohistochemistry: loose-jointed deformable heteropolymeric HRP conjugates vs. linear polymer backbone HRP conjugates. , 2013, Acta histochemica.

[31]  H. Okabe,et al.  Intraepidermal sebaceous carcinoma occurring concurrently with actinic keratosis , 2012, Journal of cutaneous pathology.

[32]  A. Fernandez-Flores Considerations on the Performance of Immunohistochemistry for Mismatch Repair Gene Proteins in Cases of Sebaceous Neoplasms and Keratoacanthomas With Reference to Muir–Torre Syndrome , 2012, The American Journal of dermatopathology.

[33]  D. Francés,et al.  Stem cell dynamics in sebaceous gland morphogenesis in mouse skin. , 2012, Developmental biology.

[34]  S. Arase,et al.  Immunohistochemical findings of sebaceous carcinoma and sebaceoma: Retrieval of cytokeratin expression by a panel of anti‐cytokeratin monoclonal antibodies , 2011, The Journal of dermatology.

[35]  S. Toda,et al.  Two histopathologic patterns of well‐differentiated extraocular sebaceous carcinoma , 2011, Journal of cutaneous pathology.

[36]  S. Arase,et al.  Sebaceous Carcinoma: An Immunohistochemical Reappraisal , 2011, The American Journal of dermatopathology.

[37]  S. Kawana,et al.  Sebaceous carcinoma of the nose with a regional metastasis following false-negative sentinel lymph node biopsy. , 2011, Acta dermato-venereologica.

[38]  H. Kutzner,et al.  What is extraocular cutaneous sebaceous carcinoma in situ? , 2010, The American Journal of dermatopathology.

[39]  R. Shahsiah,et al.  Comparative examination of androgen receptor reactivity for differential diagnosis of sebaceous carcinoma from squamous cell and basal cell carcinoma. , 2010, American journal of clinical pathology.

[40]  K. Adachi,et al.  Sebaceous carcinoma with actinic keratosis. , 2010, Acta dermato-venereologica.

[41]  W. Böcker,et al.  Immunohistochemistry: Basics and Methods , 2010 .

[42]  A. Lazar,et al.  Sebaceous neoplasia and the Muir–Torre syndrome: important connections with clinical implications , 2010, Histopathology.

[43]  T. Nagai,et al.  Ten cases of sebaceous carcinoma arising in nevus sebaceus , 2008, The Journal of dermatology.

[44]  A. Lazar,et al.  Site and Tumor Type Predicts DNA Mismatch Repair Status in Cutaneous Sebaceous Neoplasia , 2008, The American journal of surgical pathology.

[45]  M. Feinmesser,et al.  Primary Cutaneous Apocrine Carcinoma: A Clinico-pathologic Analysis of 24 Cases , 2008, The American journal of surgical pathology.

[46]  A. Cesinaro,et al.  Mismatch Repair Proteins Expression and Microsatellite Instability in Skin Lesions With Sebaceous Differentiation: A Study in Different Clinical Subgroups With and Without Extracutaneous Cancer , 2007, The American Journal of dermatopathology.

[47]  M. Nussenzweig,et al.  Blimp1 Defines a Progenitor Population that Governs Cellular Input to the Sebaceous Gland , 2006, Cell.

[48]  I. Buchwalow,et al.  A multicolor fluorescence immunostaining technique for simultaneous antigen targeting. , 2005, Acta histochemica.

[49]  J. Seykora,et al.  Cutaneous adnexal neoplasms. , 2002, American journal of clinical pathology.

[50]  P. Propping,et al.  Loss of DNA Mismatch Repair Proteins in Skin Tumors From Patients With Muir–Torre Syndrome and MSH2 or MLH1 Germline Mutations: Establishment of Immunohistochemical Analysis as a Screening Test , 2002, The American journal of surgical pathology.

[51]  Yann Barrandon,et al.  Morphogenesis and Renewal of Hair Follicles from Adult Multipotent Stem Cells , 2001, Cell.

[52]  Gina A. Taylor,et al.  Involvement of Follicular Stem Cells in Forming Not Only the Follicle but Also the Epidermis , 2000, Cell.

[53]  B. Smoller,et al.  Immunohistochemical staining for androgen receptors: a sensitive marker of sebaceous differentiation. , 1999, The American Journal of dermatopathology.

[54]  D. Ivan,et al.  Use of Immunohistochemical and Molecular Studies in the Evaluation of the Sebaceous Neoplasms , 2016 .

[55]  F. Jakobiec,et al.  Eyelid sebaceous carcinoma: clinicopathologic and multiparametric immunohistochemical analysis that includes adipophilin. , 2014, American journal of ophthalmology.

[56]  L. Wilson,et al.  A retrospective review of 1349 cases of sebaceous carcinoma , 2009, Cancer.